| Quarter (USD) | Dec 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 4 |
| Opened positions | 1 |
| Closed positions | 2 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 116.10 mm |
| Total shares | 111.16 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Morningside Venture Investments | 54.13 mm | $71.99 mm |
| Zwanziger Ventures | 42.03 mm | $3.44 mm |
| Petrichor Healthcare Capital Management | 9.65 mm | $0.00 |
| CVS CVS Health | 5.35 mm | $40.68 mm |
